Highly Active Antiretroviral Therapy-Associated Ptosis in Patients With Human Immunodeficiency Virus

被引：6
|
作者：
Silkiss, Rona Z. [1 ]
Lee, Han [1 ]
Ray, Vincent L. Gills [1 ]
机构：
[1] Calif Pacific Med Ctr, Dept Ophthalmol, San Francisco, CA 94115 USA
来源：
ARCHIVES OF OPHTHALMOLOGY | 2009年 / 127卷 / 03期
关键词：
IMMUNE-DEFICIENCY-SYNDROME; MYOPATHY;
D O I：
10.1001/archophthalmol.2009.11
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：345 / 346
页数：3
相关论文
共 50 条
  • [41] Ophthalmic Manifestations of Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy
    Sorenson, Rebecca L.
    Jeng, Bennie H.
    ARCHIVES OF OPHTHALMOLOGY, 2012, 130 (12) : 1621 - 1623
  • [42] The pathology induced by highly active antiretroviral therapy against human immunodeficiency virus: an update
    Hofman, Paul
    Nelson, Ann Marie
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (26) : 3121 - 3132
  • [43] Dermatological aspects of medicine: highly active antiretroviral therapy and the treatment of human immunodeficiency virus
    Finucane, K. A.
    Archer, C. B.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (01) : 107 - 109
  • [44] The growth and the control of human immunodeficiency virus in the lung: implications for highly active antiretroviral therapy
    White, NC
    Agostini, C
    Israel-Biet, D
    Semenzato, G
    Clarke, JR
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1999, 29 (11) : 964 - 972
  • [45] Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy
    Bhaskaran, Krishnan
    Mussini, Cristina
    Antinori, Andrea
    Walker, Ann Sarah
    Dorrucci, Maria
    Sabin, Caroline
    Phillips, Andrew
    Porter, Kholoud
    ANNALS OF NEUROLOGY, 2008, 63 (02) : 213 - 221
  • [46] Immune restoration in human immunodeficiency virus and hepatitis C virus coinfected patients after highly active antiretroviral therapy
    Antonello, Vicente Sperb
    Appel-da-Silva, Marcelo Campos
    Kliemann, Dimas Alexandre
    Santos, Breno Riegel
    Tovo, Cristiane Valle
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (05): : 551 - 554
  • [47] Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome
    Barbaro, Giuseppe
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (21) : 2208 - 2213
  • [48] Immune therapy: Non-highly active antiretroviral therapy management of human immunodeficiency virus-infected patients
    Mitsuyasu, R
    JOURNAL OF INFECTIOUS DISEASES, 2002, 185 : S115 - S122
  • [49] Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy
    Jullien, V
    Tréluyer, JM
    Rey, E
    Jaffray, P
    Krivine, A
    Moachon, L
    Lillo-Le Louet, A
    Lescoat, A
    Dupin, N
    Salmon, D
    Pons, G
    Urien, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) : 3361 - 3366
  • [50] High frequency of highly active antiretroviral therapy modifications in patients with acute or early human immunodeficiency virus infection
    Sabundayo, BP
    McArthur, JH
    Langan, SJ
    Gallant, JE
    Margolick, JB
    PHARMACOTHERAPY, 2006, 26 (05): : 674 - 681
12345